Utah Medical Products (UTMD) Gross Margin (2010 - 2026)

Utah Medical Products' Gross Margin history runs 17 years deep, the most recent figure standing at 60.56% for Q1 2026.

• On a quarterly basis, Gross Margin rose 353.0% year-over-year to 60.56% in Q1 2026; TTM through Mar 2026 was 57.94%, a 41.0% decrease from a year earlier, with the FY2025 full-year figure at 57.12%, down 191.0% from the prior year.
• Gross Margin grew to 60.56% in Q1 2026 per UTMD's latest filing, from 58.2% in the prior quarter.
• Across five years, Gross Margin topped out at 63.19% in Q3 2022 and bottomed at 56.21% in Q2 2025.
• The 5-year median for Gross Margin is 59.66% (2024), against an average of 59.45%.
• Across the five-year window, Gross Margin slumped 434 bps in 2023 and jumped 353 bps in 2026, its largest moves.
• Year by year, Gross Margin stood at 61.34% in 2022, then fell by 6 bps to 57.55% in 2023, then climbed by 1 bps to 58.13% in 2024, then rose by 0 bps to 58.2% in 2025, then climbed by 4 bps to 60.56% in 2026.
• Per Business Quant, the three latest UTMD Gross Margin figures stand at 60.56% (Q1 2026), 58.2% (Q4 2025), and 57.11% (Q3 2025).